Collectively, these studies provide converging evidence that Hsp90 plays critical roles in the pathophysiology of autoimmune bullous skin diseases by supporting pathogenic autoantibody production, neutrophil effector functions, and keratinocyte inflammatory responses. Here, HSP90AA1 is linked to autoimmune bullous skin disease.